Loading…
SANUWAVE Health, Inc. is projected to rise to $7.19 by 2027, a +14% move from its current price of $6.31. SNWV is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $6.00 | $6.32 | $6.65 | +0.10% |
| Aug 6 | $5.88 | $6.32 | $6.80 | +0.19% |
| Aug 7 | $5.79 | $6.33 | $6.92 | +0.29% |
| Aug 8 | $5.72 | $6.33 | $7.02 | +0.39% |
| Aug 9 | $5.65 | $6.34 | $7.11 | +0.49% |
| Aug 10 | $5.60 | $6.35 | $7.20 | +0.58% |
| Aug 11 | $5.55 | $6.35 | $7.27 | +0.68% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.55 | $6.35 | $7.27 | +0.68% |
| Week 2 | $5.28 | $6.40 | $7.75 | +1.37% |
| Week 3 | $5.09 | $6.44 | $8.14 | +2.06% |
| Week 4 | $4.94 | $6.48 | $8.50 | +2.75% |
| Week 5 | $4.82 | $6.53 | $8.84 | +3.45% |
| Week 6 | $4.72 | $6.57 | $9.16 | +4.15% |
| Week 7 | $4.62 | $6.62 | $9.47 | +4.86% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures.
The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds.
Founded in 2004 and headquartered in Eden Prairie, Minnesota, SANUWAVE Health operates within Healthcare.
SANUWAVE Health, Inc. (SNWV) is a healthcare-focused medical device company.
The stock is trading at $6.07, with a market cap of $52.15M, and it ranks 4491.
Near-term, the technical picture is bearish with RSI14 at 30. The stock’s simple moving averages are $12.71 for the SMA50 and $23.07 for the SMA200, with a defined support at $6.07 and a resistance at $14.91. There is a 30-day price range from $3.97 to $9.27.
The year-by-year forecast shows a neutral stance in 2026 with min $6.07, avg $6.07, max $10.02 and ROI 0%, followed by a neutral path through 2030 with min $3.63, avg $5.87, max $10.17 and ROI -3.3%; from 2031 onward the outlook turns bullish, with rising averages and ROIs (2031 avg $7.36, ROI 21.4%; 2032 avg $9.16, ROI 51.1%; 2033 avg $9.85, ROI 62.3%; 2034 avg $10.58, ROI 74.4%; 2035 avg $9.76, ROI 60.9%).
A major floor 70.1% below — a decisive break under it would weaken the trend.
The nearest floor, 6.2% below — buyers have tended to step in here.
The nearest ceiling, 91.7% above — a clean break opens room to run.
A major ceiling 226.6% above — clearing it would confirm fresh momentum.
Key SNWV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SNWV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.26 | Buy | $6.25 | Buy |
| MA 10 | $6.16 | Buy | $6.58 | Sell |
| MA 20 | $8.01 | Sell | $7.61 | Sell |
| MA 50 | $11.02 | Sell | $10.50 | Sell |
| MA 100 | $14.69 | Sell | $14.39 | Sell |
| MA 200 | $21.94 | Sell | $19.32 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.69 | Neutral |
| Stoch RSI (14) | 13.10 | Buy |
| CCI (20) | -55.11 | Neutral |
| Williams %R (14) | -95.86 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | -15.13 | Sell |
| Bollinger %B (20,2) | 0.31 | Neutral |
| Stochastic %K (14) | 4.14 | Buy |
| TRIX (15) | -2.12 | Sell |
| Awesome (5,34) | -2.56 | Sell |
| Ultimate (7,14,28) | 47.97 | Neutral |
| Momentum (10) | -0.22 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 6.38 | Sell |
| ADX (14) | 30.94 | Sell |
| ATR (14) | 0.48 | Info |
The 30-day technical picture shows BEARISH sentiment, with RSI14 at 30.
Prices are currently near support at $6.07 and face resistance at $14.91, with SMA50 at $12.71 and SMA200 at $23.07 above the current price. The 30-day range runs from $3.97 to $9.27, highlighting recent volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.92 | $6.31 | $9.89 | 0% | Neutral | |
| $5.28 | $7.19 | $10.57 | +14% | Neutral | |
| $4.71 | $6.80 | $10.65 | +8% | Neutral | |
| $4.42 | $6.70 | $11.01 | +6% | Neutral | |
| $4.18 | $6.64 | $11.34 | +5% | Neutral | |
| $4.89 | $8.09 | $14.30 | +28% | Bullish | |
| $5.70 | $9.81 | $17.87 | +56% | Bullish | |
| $6.10 | $10.92 | $20.42 | +73% | Bullish | |
| $6.08 | $11.28 | $21.63 | +79% | Bullish | |
| $5.52 | $10.61 | $20.81 | +68% | Bullish | |
| $7.08 | $15.74 | $33.85 | +149% | Bullish | |
| $11.27 | $25.05 | $57.62 | +297% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.92 | $6.31 | $8.00 | +0.00% |
| September 2026 | $5.69 | $6.90 | $8.72 | +9.32% |
| October 2026 | $5.61 | $6.89 | $8.88 | -0.07% |
| November 2026 | $5.58 | $6.93 | $9.07 | +0.51% |
| December 2026 | $5.94 | $7.45 | $9.89 | +7.57% |
Click any year to see its month-by-month SNWV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SNWV to range from $5.92 to $9.89 through 2026. The $6.31 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The SNWV price prediction for 2027 points to an average of $7.19 (low $5.28, high $10.57) — a potential gain of +14% on today's $6.31. Price action looks broadly range-bound.
In 2028, SNWV is projected to trade between $4.71 and $10.65, averaging $6.80 — a potential gain of +8% from today's $6.31. That is -5% versus the projected 2027 average. A consolidation phase looks the most probable path here.
SANUWAVE Health, Inc.'s 2029 outlook centres on $6.70, within a $4.42 to $11.01 range. That is -1% versus the projected 2028 average. That marks a +6% change versus current levels. Price action looks broadly range-bound.
By 2030, SNWV could reach as high as $11.34, with a base case around $6.64 and support toward $4.18 — roughly +5% from $6.31. A consolidation phase looks the most probable path here.
Expect SNWV to range from $4.89 to $14.30 through 2031. The $8.09 average target implies a +28% move from current prices. That is up +22% on the projected 2030 average. Momentum favours further upside here.
The SNWV price prediction for 2032 points to an average of $9.81 (low $5.70, high $17.87) — a potential gain of +56% on today's $6.31. Buyers look set to stay in control over this stretch.
In 2033, SNWV is projected to trade between $6.10 and $20.42, averaging $10.92 — a potential gain of +73% from today's $6.31. That is up +11% on the projected 2032 average. Momentum favours further upside here.
SANUWAVE Health, Inc.'s 2034 outlook centres on $11.28, within a $6.08 to $21.63 range. That is up +3% on the projected 2033 average. That marks a +79% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, SNWV could reach as high as $20.81, with a base case around $10.61 and support toward $5.52 — roughly +68% from $6.31. Momentum favours further upside here.
Expect SNWV to range from $7.08 to $33.85 through 2040. The $15.74 average target implies a +149% move from current prices. That is up +48% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The SNWV price prediction for 2050 points to an average of $25.05 (low $11.27, high $57.62) — a potential gain of +297% on today's $6.31. Momentum favours further upside here.
Investing $1,000 in SNWV today (≈ 158.478605 SNWV) could be worth
$3,970.53
+$2,970.53 (+297%) by 2050 · US Dollar
Based on the average projected SNWV price of $25.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SNWVwould be worth at today's price.
$1,000 invested in SNWV on Jul 31, 2025 (≈ 25.99428 SNWV) would be worth
$164.02
-$835.98 (-83.6%) today · 0.16× · US Dollar
Based on a SNWV entry price of $38.47 vs. today's $6.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.93 | $1,064.08 | +6.4% |
| 1 month ago | $10.6 | $595.28 | -40.5% |
| 3 months ago | $15.73 | $401.14 | -59.9% |
| 6 months ago | $26.64 | $236.86 | -76.3% |
| 1 year ago | $38.47 | $164.02 | -83.6% |
| All time (1.8y) ago | $13.02 | $484.45 | -51.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SNWV forecast.
Our base-case forecast reaches $13.00 around 2040.
Implied market cap at $13.00: $111.79M
In the near-to-mid term, the 2026-2030 forecast sits neutral: 2026 min $6.07, avg $6.07, max $10.02, ROI 0%; 2027 min $4.89, avg $6.73, max $10.01, ROI 11%; 2028 min $4.36, avg $6.38, max $10.12, ROI 5.2%; 2029 min $4.19, avg $6.45, max $10.74, ROI 6.3%; 2030 min $3.63, avg $5.87, max $10.17, ROI -3.3%.
From 2031 onward the forecast shifts to bullish sentiment with rising averages: 2031 avg $7.36, ROI 21.4%; 2032 avg $9.16, ROI 51.1%; 2033 avg $9.85, ROI 62.3%; 2034 avg $10.58, ROI 74.4%; 2035 avg $9.76, ROI 60.9%.
Further out, the outlook strengthens: 2040 avg $14.31, ROI 136%; and 2050 avg $22.46, ROI 270.2%.
Overall, the long-term forecast points to meaningful upside in the later years, with bullish sentiment and substantial ROIs, while near-term periods show more modest or flat expected performance. These figures are estimates and not guarantees of future results.
Tap a question to reveal the answer.
2030 avg $5.87; max $10.17; ROI -3.3%; sentiment Neutral.
Near-term 2026-2030 is Neutral, with 2026 ROI 0%. From 2031 onward the forecast is Bullish with increasing averages and ROIs (e.g., 2031 avg $7.36, ROI 21.4%; 2050 avg $22.46, ROI 270.2%).
Yes. The forecast shows 2026 max $10.02 and 2030 max $10.17, with higher maxima later (e.g., 2032 max $16.96, 2033 max $18.73, 2040 max $31.41, 2050 max $51.65).
Current price is $6.07 and market cap is $52.15M.
The 30-day range is $3.97 to $9.27.
SANUWAVE Health, Inc. Community Discussion
0Share your SANUWAVE Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.